References
- Ibáñez L, de Zegher F.Ethinylestradiol–drospirenone, flutamide–metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. J Clin Endocrinol Metab 2004;89:1592–1597.
- Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R.Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 1987;84:8282–8286.
- Tuuri T, Eramaa M, Hilden K, Ritvos O.The tissue distribution of activin alpha and beta subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 1994; 78:1521–1524.
- Mather JP, Moore A, Li RH.Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proc Soc Exp Biol Med 1997;215:209–222.
- Flanagan JN, Linder K, Mejhert N, Dungner E, Wahlen K, Decaunes P, Rydén M, Björklund P, Arver S, Bhasin S, et al Role of follistatin in promoting adipogenesis in women. J Clin Endocrinol Metab 2009;94:3003–3009.